Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant

BACKGROUND: Antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after mRNA or adenoviral vector-based vaccines is weak in kidney transplant (KT) patients. However, few studies have focused on humoral response after inactivated virus-based vaccines in KT. Here, we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Seija, Mariana, Rammauro, Florencia, Santiago, José, Orihuela, Natalia, Zulberti, Catherine, Machado, Danilo, Recalde, Cecilia, Noboa, Javier, Frantchez, Victoria, Astesiano, Rossana, Yandián, Federico, Guerisoli, Ana, Morra, Álvaro, Cassinelli, Daniela, Coelho, Cecilia, de Aramburu, Belén, González-Severgnini, Paulina, Moreno, Romina, Pippolo, Aldana, López, Gabriela, Lemos, Mónica, Somariva, Lorena, López, Eliana, Fumero, Soledad, Orihuela, Carla, Rodríguez, Rosalía, Acuña, Gonzalo, Rabaza, Victoria, Perg, Nancy, Cordero, Rossana, Reisfeld, Cristina, Olivera, Paula, Montero, Paola, Nogueira, Cecilia, Nalerio, Catheryn, Orihuela, Sergio, Curi, Lilián, Burgstaller, Ema, Noboa, Oscar, Pritsch, Otto, Nin, Marcelo, Bianchi, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755301/
https://www.ncbi.nlm.nih.gov/pubmed/35198159
http://dx.doi.org/10.1093/ckj/sfab291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755301/
https://www.ncbi.nlm.nih.gov/pubmed/35198159
http://dx.doi.org/10.1093/ckj/sfab291

Ejemplares similares